DURECT Corporation Accrued Expenses

Accrued Expenses of DRRX for past 10 years: annual, quarterly and twelve month trailing (TTM) including Accrued Expenses growth rates and interactive chart. Accrued expense is expense which has been incurred but not yet paid. Expense must be recorded in the accounting period in which it is incurred. Therefore, accrued expense must be recognized in the accounting period in which it occurs rather than in the following period in which it will be paid.

Highlights and Quick Summary

  • Accrued Expenses for the quarter ending June 30, 2023 was $7.78 Million (a 5.29% increase compared to previous quarter)
  • Year-over-year quarterly Accrued Expenses increased by 24.66%
  • Annual Accrued Expenses for 2022 was $7.9 Million (a 16.13% increase from previous year)
  • Annual Accrued Expenses for 2021 was $6.8 Million (a 7.14% increase from previous year)
  • Annual Accrued Expenses for 2020 was $6.35 Million (a 6.84% increase from previous year)
Visit stockrow.com/DRRX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Accrued Expenses of DURECT Corporation

Most recent Accrued Expensesof DRRX including historical data for past 10 years.

Interactive Chart of Accrued Expenses of DURECT Corporation

DURECT Corporation Accrued Expenses for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 $7.78 $7.39 – – –
2022 $7.9 $6.24 $4.54 $4.89 $7.9
2021 $6.8 $5.74 $5.11 $4.09 $6.8
2020 $6.35 $4.67 $3.69 $3.46 $6.35
2019 $5.94 $4.51 $4.38 $4.32 $5.94
2018 $4.67 $5.2 $4.52 $4.92 $4.67
2017 $5.51 $5.72 $4.1 $3.29 $5.51
2016 $5.06 $4.09 $4.77 $4.55 $5.06
2015 $4.97 $4.69 $3.77 $3.19 $4.97
2014 $5.05 $5.02 $4.69 $3.87 $5.05
2013 $5.87 $4.1 $3.96 $3.59 $5.87
2012 $4.0 $3.76 – – $4.0

Business Profile of DURECT Corporation

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic
© stockrow.com